News &amp; Updates

Adults with elevated blood pressure (BP) may benefit from help provided by dietitians, suggests a study.

Dietitians can help improve outcomes in hypertensive adults

11 Jun 2024

Oral tacrolimus benefits haemodialysis patients with uraemic pruritus

A study from Iran presented at ERA 2024 demonstrated the potential of oral tacrolimus to deliver an antipruritic effect in haemodialysis patients with uraemic pruritus.

Oral tacrolimus benefits haemodialysis patients with uraemic pruritus

Mediterranean diet may lower death risk in women

Higher adherence to the Mediterranean diet confers a 23-percent reduction in the risk of all-cause mortality, a benefit that may be partially explained by potential mediation by several cardiometabolic factors, according to a study.

Mediterranean diet may lower death risk in women

One-fifth of people attempting suicide have no prior mental disorders

One in five individuals who attempt suicide do not have a history of psychiatric disorders, a cross-sectional study has shown.

One-fifth of people attempting suicide have no prior mental disorders

Tirzepatide resolves MASH without worsening fibrosis

Treatment with tirzepatide for 52 weeks resulted in MASH* resolution, with no worsening of fibrosis in patients with MASH and fibrosis in the phase II SYNERGY-NASH trial.

Tirzepatide resolves MASH without worsening fibrosis

Autism’s skewed gender ratio explained

The skewed gender ratio in autism spectrum disorder (ASD) may be explained by differences in heritability in males and females, an international study has found.

Autism’s skewed gender ratio explained

11 Jun 2024

Survival, hospitalization outcomes similar between biweekly, thrice-weekly dialysis schedules

10 Jun 2024 by

A twice-weekly haemodialysis schedule does not appear to increase death and hospitalization rates at 2 years compared with a thrice-weekly schedule, although some patients on the biweekly schedule may require medication dose adjustments, as reported in the prospective multicentre nonrandomized TATH* trial.

Survival, hospitalization outcomes similar between biweekly, thrice-weekly dialysis schedules

Higher serum 25(OH)D concentration tied to lower CVD, deaths in CKD

Increased concentrations of serum 25-hydroxyvitamin D (25[OH]D) appear to have beneficial effects in patients with chronic kidney disease (CKD), as indicated by lower risks of cardiovascular disease (CVD) incidence and mortality, as shown in a prospective study.

Higher serum 25(OH)D concentration tied to lower CVD, deaths in CKD

10 Jun 2024

Iptacopan safe, effective in patients with C3G

10 Jun 2024 by

Use of iptacopan along with supportive care results in significant reductions in proteinuria at 6 months in patients with C3 glomerulopathy (C3G), a rare and severe form of proliferative glomerulonephritis brought about by the dysregulation of alternative complement pathway (AP), as shown in the APPEAR-C3G study. It is also well tolerated and has a favourable safety profile.

Iptacopan safe, effective in patients with C3G

Reduced-dose DOACs tied to lower stroke incidence vs warfarin